In vitro assays showed that the knockdown of HDAC2 and the treatment with Romidepsin rescued the anti‐tumor effect of PJA2 in SW480 and RKO cells (Figure 7D; Figure S9D–G, Supporting Information). The gene discussed is HDAC2; the disease is neoplasm.